Adverse Drug Reactions Flashcards

1
Q

What is an adverse drug reaction (ADR)

A

Any response to a drug which is noxious, unintended and occurs at doses used in man for prophylaxis, diagnosis or treatment

An appreciably harmful or unpleasant reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What does an ADR result in

A

An intervention related to the use of a medicinal product, which predicts hazard from future administration and warrants prevention or specific treatment, or alteration of the dosage regimen, or withdrawal of the product

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How many people are admitted annually due to ADR’s

A

1,000,000 (6.5% of all hospital admissions)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How many inpatients suffer an ADR

A

10-20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How many deaths a year are due to ADR

A

5000 - 12,000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the 4th leading cause of death

A

ADR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What type of onset can ADR show

A

Acute
Sub-acute
Latent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe acute ADR

A

Occur within 60 minutes (e.g. bronchoconstriction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe sub-acute ADR

A

Occurs within 1 to 24 hours

Can present with rash and serum sickness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe latent ADR

A

Occurs after 2 days

May show eczematous eruptions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the three classes of severity of ADR

A

Mild
Moderate
Severe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe a mild ADR

A

It is bothersome but requires no change in therapy (e.g. metallic taste with metronidazole)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe a moderate ADR

A

It requires change in therapy, additional treatment and hospitalization (e.g. amphotericin induced hypokalemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe a severe ADR

A

Causes a disabling or life-threatening condition (e.g. kidney failure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How are ADRs classified (6)

A
Type A - Augmented
Type B - Bizarre
Type C - Chronic
Type D - Delayed
Type E - End of treatment   
Type F - Failure of treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe a type A ADR

A

It causes normal but augmented response to the pharmacological actions of a drug
It is dose related and predictable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe a type B ADR

A

It causes Bizarre effects

It is idiosyncratic and unpredictable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are predisposing factors to ADRs

A
Multiple Drug Therapy
Inter-current Disease (e.g. renal and hepatic impairment)
Race and Genetic Polymorphisms
Age (e.g. elderly and neonates)
Sex (e.g. ADRs more common in women)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are type A ADRs due to

A

Excess pharmacological action (e.g.
Bradycardia with beta-blockers or Hypoglycaemia with sulphonylureas or insulin)
The secondary pharmacology of a drug unrelated to the therapeutic effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What type of ADR is the most common

A

Type A (account for 80% of all ADRs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How can type A be treated

A

Its easily reversible by reducing the dose or stopping the drug
Not usually life threatening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What types of type A ADRs are there

A

Augmentation of the primary effect

Secondary effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the reasons for a type A ADR

A

Too high a dose
Pharmaceutical variation
Pharmacokinetic variation
Pharmacodynamic variation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

When do pharmacokinetic variation and pharmacodynamic variation occur

A

Normally due to a result of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What can pharmacokinetic variation involve

A

Absorption (e.g. dose, formulation, GI motility, first pass metabolism)
Distribution
Metabolism (e.g. enhanced or impaired hepatic function)
Elimination (e.g. renal disease, reduced GFR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What do ADRs that arise from absorption mainly result in

A

Therapeutic failure

27
Q

When is liver disease important

A

When drugs have a narrow therapeutic index

28
Q

What is the importance of pharmacogenetics

A

A number of drugs are metabolised via acetylation which is under genetic control

29
Q

Name some pharmacogenetic factors

A

10% of the population are slow metabolisers
Prone to drug toxicity
peripheral Neuropathy with isoniazid

30
Q

What will renal and hepatic impairment have on drug use

A

Toxic drug levels may build up

31
Q

What effect will cardiac failure have on drug usage

A

Drug absorption from the gut may reduce due to oedema
Poor renal perfusion and decreased GFR
Hepatic congestion

32
Q

What are type B ADRs (8)

A
Bizarre
Unpredictable
Rare
Cause serious illness or death
Unidentified for months or years
Unrelated to the dose
Not readily reversed
33
Q

What are type B ADRs commonly associated with

A

Macromolecules (e.g. proteins, vaccines and polypeptides)

34
Q

Who can type B ADRs affect

A

Patients with a history of asthma or excema

35
Q

Why is the HLA status important in type B ADRs

A

Presence of particular HLA increases risk of a type B reaction

36
Q

What are the mechanisms for ADRs

A

Idiosyncratic

Drug allergy or hypersensitivity

37
Q

Describe how the drug allergy or hypersensitivity present (5)

A

Immunological
No relation to the pharmacological action of the drug
Delay between exposure and ADR
No dose response curve
Manifests as rash, asthma, serum sickness

38
Q

What is an idiosyncratic response

A

An inherent abnormal response to a drug due to genetic abnormalities such as enzyme deficiency or abnormal receptor activity

It involves pharmacogenetics and pharmacodynamics

39
Q

How can the responses to drugs be considered

A

Genetic

Immunological

40
Q

Describe the ADR that occurs in patients with the enzyme abnormality, Erythrocyte glucose 6-phosphate dehydrogenase (G6PD) deficiency

A

Individuals with sex linked inherited deficiency of this enzyme are susceptible to red cell haemolysis when given drugs such as primaquine or sulphonamides

41
Q

Describe the ADR that occurs in patients with the receptor abnormalities

A

Malignant hyperthermia with general anaesthetics

42
Q

Why do drug allergy hypersensitivity reactions occur

A

Due to antigen- antibody interaction

43
Q

How do drug allergy hypersensitivity reactions occur

A

The first dose acts as the antigen
Body produces the antibody
Subsequent antigen-antibody reaction

44
Q

What are type C ADRs related to

A

The duration of treatment as well as the dose and does not occur with a single dose
They are semi-predictable

45
Q

Give examples of type C ADRs (5)

A

Iatrogenic Cushings disease
Steroid induced osteoporosis
Opiate dependence
Tardive dyskinesia with neuroleptic drugs
Analgesic nephropathy due to paracetamol or NSAIDs

46
Q

What are type D ADRs

A

Averse effects which occur a long time after treatment

47
Q

What can type D ADRs cause

A

Teratogenesis

Carcinogenesis in treated patients years after treatment has stopped (or children of treated patients)

48
Q

In who can type D second cancers occur

A

In those treated with alkylating agents or immunosuppressive agents (e.g. cyclophosphamide or alkylating agents)

49
Q

What kind of malformations can occur in children whose mothers were treated with isotretinoin

A

Craniofacial

50
Q

What is teratogenesis

A

The abnormal congenital malformations in the fetus following in utero exposure due to maternal medication use during 1st trimester of pregnancy

51
Q

Name some teratogenic agents

A
Cytotoxics
Vitamin A
Antithyroid drugs
Steroids
Oral nticoagulants

All drugs should be avoided during pregnancy unless they are safe or the benefit outweighs potential risk

52
Q

What are type E ADRs

A

Adverse effects which occur when a drug treatment is stopped especially suddenly following long-term use (e,g, alcohol)

53
Q

Give examples of what type E ADRs can cause

A

Unstable angina and MI when beta blockers are stopped.
Addisonian crisis when long term steroids are suddenly stopped
Withdrawal seizures when anti-epileptics are stopped

54
Q

When does rebound phenomena occur

A

When a drug is suddenly withdrawn (e.g. alcohol, benzodiazepines, beta-blockers, corticosteroids)

55
Q

Describe type F ADRs

A

Failure of therapy
Common
Dose related
Frequently caused by drug interactions

56
Q

Give an example of a type F ADR

A

The failure of the OCP when administered with hepatic enzyme inducers/ antibiotics

57
Q

How can ADRs be diagnosed

A

Step 1: Differential diagnosis
Step 2: Medication History (past & present)
Step 3: Assess time of onset and dose relationship
Step 4: Laboratory investigations (plasma concentration measurement, allergy tests)

58
Q

Who are most at risk of ADRs (at least 5)

A
Children and elderly
Multiple medications
Multiple co-morbid conditions
Inappropriate medication prescribing, use, or monitoring
End-organ dysfunction
Altered physiology
Prior history of ADRs
Extent (dose) and duration of exposure
Genetic predisposition
59
Q

What drugs are commonly involved in ADRs (at least 5)

A
Antibiotics
Antineoplastics
Anticoagulants
Cardiovascular drugs
Hypoglycemics
Antihypertensives
NSAID/Analgesics
Diagnostic agents
CNS drugs 
Opiates
60
Q

How many fatal ADRs do antineoplastics, cardiovascular drugs and CNS drugs account for

A

69%

61
Q

What body systems are commonly involved in ADRs (at least 5)

A
Haematologic
CNS 
Dermatologic/Allergic
Metabolic
Cardiovascular
Gastrointestinal
Renal/Genitourinary
Respiratory
Sensory
62
Q

When should ADRs be reported

A

All significant or unusual adverse drug reactions as well as unanticipated or novel events that are suspected to be drug related
All ADRs affecting Black Triangle Drugs/Products

63
Q

How can ADRs be reported

A

Using ADR yellow card scheme